265 filings
Page 2 of 14
6-K
GLMD
Galmed Pharmaceuticals Ltd
18 Jul 23
Current report (foreign)
9:25am
424B4
GLMD
Galmed Pharmaceuticals Ltd
18 Jul 23
Prospectus supplement with pricing info
9:23am
EFFECT
GLMD
Galmed Pharmaceuticals Ltd
17 Jul 23
Notice of effectiveness
12:15am
6-K
GLMD
Galmed Pharmaceuticals Ltd
14 Jul 23
Galmed Pharmaceuticals Announces Pricing of $7 Million Public Offering
9:44am
F-1/A
GLMD
Galmed Pharmaceuticals Ltd
13 Jul 23
Registration statement (foreign) (amended)
5:08pm
CORRESP
GLMD
Galmed Pharmaceuticals Ltd
12 Jul 23
Correspondence with SEC
12:00am
F-1/A
GLMD
Galmed Pharmaceuticals Ltd
12 Jul 23
Registration statement (foreign) (amended)
12:00am
CORRESP
GLMD
Galmed Pharmaceuticals Ltd
12 Jul 23
Correspondence with SEC
12:00am
6-K
GLMD
Galmed Pharmaceuticals Ltd
10 Jul 23
Current report (foreign)
8:10am
FWP
GLMD
Galmed Pharmaceuticals Ltd
28 Jun 23
Free writing prospectus
8:40am
F-1/A
GLMD
Galmed Pharmaceuticals Ltd
28 Jun 23
Registration statement (foreign) (amended)
8:37am
F-1
GLMD
Galmed Pharmaceuticals Ltd
16 Jun 23
Registration statement (foreign)
4:15pm
6-K
GLMD
Galmed Pharmaceuticals Ltd
1 Jun 23
Galmed Pharmaceuticals Reports First Quarter 2023 Financial Results
8:14am
6-K
GLMD
Galmed Pharmaceuticals Ltd
12 May 23
Current report (foreign)
7:00am
6-K
GLMD
Galmed Pharmaceuticals Ltd
11 May 23
Current report (foreign)
4:15pm
6-K
GLMD
Galmed Pharmaceuticals Ltd
9 May 23
Current report (foreign)
7:14am
6-K
GLMD
Galmed Pharmaceuticals Ltd
4 May 23
Current report (foreign)
4:15pm
6-K
GLMD
Galmed Pharmaceuticals Ltd
4 May 23
Galmed Pharmaceuticals forms a Strategic Partnership
4:14pm
6-K
GLMD
Galmed Pharmaceuticals Ltd
30 Mar 23
Current report (foreign)
4:27pm
20-F
2022 FY
GLMD
Galmed Pharmaceuticals Ltd
Annual report (foreign)
29 Mar 23
4:30pm